Human CD19-CAR-NK cells modified to overexpress CXCR4 through bicistronic lentiviral transduction augmented more than two-fold the migration to CD19+ tumor cells compared to huCAR19 NK cells (328). This evidence concerns the gene CD19 and neoplasm.